Pfizer’s
-
Middle East
A major Israeli study of Pfizer’s COVID-19 vaccine shows a 94 per cent reduction in symptomatic infections
sbs- Israel’s largest healthcare provider on Sunday reported a 94 per cent drop in symptomatic COVID-19 infections among 600,000 people…
Read More »